RGSL1

gene
On this page

Summary

RGSL1 (regulator of G protein signaling like 1, HGNC:18636) is a protein-coding gene on chromosome 1q25.3, encoding Regulator of G-protein signaling protein-like (A5PLK6).

Predicted to be located in membrane.

Source: NCBI Gene 353299 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 168 total
  • MANE Select transcript: NM_001137669

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18636
Approved symbolRGSL1
Nameregulator of G protein signaling like 1
Location1q25.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000121446
Ensembl biotypeprotein_coding
OMIM611012
Entrez353299

Gene structure

Transcript identifiers

Ensembl transcripts: 22 — 8 protein_coding, 6 nonsense_mediated_decay, 5 protein_coding_CDS_not_defined, 3 retained_intron

ENST00000294854, ENST00000367561, ENST00000415960, ENST00000416676, ENST00000422241, ENST00000426890, ENST00000427189, ENST00000436031, ENST00000437548, ENST00000443996, ENST00000444367, ENST00000447374, ENST00000456971, ENST00000634342, ENST00000634626, ENST00000634679, ENST00000634723, ENST00000634758, ENST00000634801, ENST00000635407, ENST00000635539, ENST00000648414

RefSeq mRNA: 2 — MANE Select: NM_001137669 NM_001137669, NM_001366934

CCDS: CCDS58049

Canonical transcript exons

ENST00000294854 — 22 exons

ExonStartEnd
ENSE00002342422182488980182489202
ENSE00002606110182450146182450178
ENSE00003468888182553455182553541
ENSE00003495994182458319182458393
ENSE00003498764182551100182551209
ENSE00003507074182530244182530361
ENSE00003511615182548317182548455
ENSE00003523613182548700182548824
ENSE00003534828182472396182472557
ENSE00003545570182556024182556222
ENSE00003571805182488285182488347
ENSE00003591040182493022182493129
ENSE00003598910182554627182554693
ENSE00003603675182453958182454040
ENSE00003614882182527579182527772
ENSE00003614898182540247182540421
ENSE00003621365182473575182474542
ENSE00003641397182532662182532791
ENSE00003670089182522004182522109
ENSE00003683257182530790182530910
ENSE00003692856182460004182460133
ENSE00003850188182560279182560597

Expression profiles

Bgee: expression breadth broad, 84 present calls, max score 88.64.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0183 / max 20.7499, expressed in 4 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
70410.01834

Top tissues by expression

230 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cervix squamous epitheliumUBERON:000692288.64gold quality
type B pancreatic cellCL:000016988.32gold quality
olfactory bulbUBERON:000226487.32gold quality
tongue squamous epitheliumUBERON:000691987.17gold quality
left testisUBERON:000453383.49gold quality
right testisUBERON:000453483.16gold quality
male germ cellCL:000001581.50silver quality
testisUBERON:000047380.83gold quality
spermCL:000001980.74silver quality
thymusUBERON:000237077.79gold quality
diaphragmUBERON:000110377.44gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.16gold quality
upper arm skinUBERON:000426376.82gold quality
cervix epitheliumUBERON:000480175.74gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099174.97gold quality
orbitofrontal cortexUBERON:000416774.03gold quality
epithelium of nasopharynxUBERON:000195173.87gold quality
hair follicleUBERON:000207373.31gold quality
CA1 field of hippocampusUBERON:000388172.98gold quality
epithelial cell of pancreasCL:000008372.82gold quality
mucosa of urinary bladderUBERON:000125972.69gold quality
layer of synovial tissueUBERON:000761672.41gold quality
cardia of stomachUBERON:000116272.15gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451172.08gold quality
dorsal plus ventral thalamusUBERON:000189772.04gold quality
pharyngeal mucosaUBERON:000035571.62gold quality
tracheaUBERON:000312671.53gold quality
subthalamic nucleusUBERON:000190671.51gold quality
ventral tegmental areaUBERON:000269171.46gold quality
vastus lateralisUBERON:000137971.27gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.28

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 3)

  • A detailed mapping of the breakpoints revealed intragenic microdeletions affecting the coding regions of RGSL2, RGSL1. (PMID:18521847)
  • Missense mutations in RGSL1 gene is associated with breast cancer. (PMID:21135262)
  • Data indicate that multiplex ligation-dependent probe amplification (MLPA) probes (Fig. 2) corresponding to the RGSL2, RGSL1 and RGS16 genes showed 64.5 % tumour samples with copy number gains and 5 % tumour samples with copy number losses. (PMID:23248035)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusRgsl1ENSMUSG00000042641
rattus_norvegicusRgsl1ENSRNOG00000026952

Paralogs (23): RGS11 (ENSG00000076344), RGS1 (ENSG00000090104), RGS17 (ENSG00000091844), AXIN1 (ENSG00000103126), RGS9 (ENSG00000108370), RGS2 (ENSG00000116741), RGS4 (ENSG00000117152), RGS13 (ENSG00000127074), RGS22 (ENSG00000132554), RGS8 (ENSG00000135824), RGS3 (ENSG00000138835), RGS5 (ENSG00000143248), RGS16 (ENSG00000143333), RGS20 (ENSG00000147509), RGS10 (ENSG00000148908), RGS18 (ENSG00000150681), RGS12 (ENSG00000159788), AXIN2 (ENSG00000168646), RGS14 (ENSG00000169220), RGS19 (ENSG00000171700), RGS6 (ENSG00000182732), RGS7 (ENSG00000182901), RGS21 (ENSG00000253148)

Protein

Protein identifiers

Regulator of G-protein signaling protein-likeA5PLK6 (reviewed: A5PLK6)

All UniProt accessions (14): A0A0U1RQD8, A0A0U1RRA3, A0A0U1RRF3, A0A0U1RRF6, A0A0U1RRG0, A0A0U1RRN0, A0A3B3ISC9, A5PLK6, H3BNQ0, H3BNR3, H3BNS3, H3BRN5, H3BU64, H3BVE8

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Isoforms (6)

UniProt IDNamesCanonical?
A5PLK6-11yes
A5PLK6-22
A5PLK6-33
A5PLK6-44
A5PLK6-55
A5PLK6-66

RefSeq proteins (2): NP_001131141, NP_001353863 (=MANE)

Domains & families (InterPro)

IDNameType
IPR016137RGSDomain
IPR036305RGS_sfHomologous_superfamily
IPR044926RGS_subdomain_2Homologous_superfamily
IPR053282RGS_domain-containingFamily

Pfam: PF00615

UniProt features (17 total): splice variant 8, sequence variant 2, sequence conflict 2, chain 1, transmembrane region 1, domain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A5PLK6-F167.790.08

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-416476G alpha (q) signalling events
R-HSA-418594G alpha (i) signalling events
R-HSA-418597G alpha (z) signalling events

MSigDB gene sets: 34 (showing top): MULLIGHAN_NPM1_SIGNATURE_3_UP, REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS, TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN, WTGAAAT_UNKNOWN, YY1_01, REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS, QI_PLASMACYTOMA_DN, MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP, chr1q25, CTIP_DN.V1_UP, MIR4700_5P, MIR6129, MIR4510, MIR6130, MIR4667_5P

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): membrane (GO:0016020)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
GPCR downstream signalling3

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

662 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RGSL1TEX35Q5T0J7896
RGSL1RALGPS2Q86X27842
RGSL1RGS8P57771792
RGSL1RGS16O15492792
RGSL1RGS13O14921777
RGSL1RGS17Q9UGC6776
RGSL1RGS18Q9NS28776
RGSL1RGS20O76081771
RGSL1RGS21Q2M5E4771
RGSL1RGS5O15539764
RGSL1RGS6P49758761
RGSL1RGS10O43665759
RGSL1RGS12O14924758
RGSL1RGS11O94810756
RGSL1RGS19P49795746

IntAct

3 interactions, top by confidence:

ABTypeScore
DCUN1D1RGSL1psi-mi:“MI:0914”(association)0.350
Ppsi-mi:“MI:0914”(association)0.350

BioGRID (9): RGSL1 (Two-hybrid), RGSL1 (Synthetic Lethality), MAGT1 (Proximity Label-MS), RGSL1 (Affinity Capture-RNA), D2HGDH (Co-fractionation), REXO2 (Co-fractionation), RGSL1 (Cross-Linking-MS (XL-MS)), RGSL1 (Cross-Linking-MS (XL-MS)), RGSL1 (Affinity Capture-MS)

ESM2 similar proteins: A2RRS8, A4D1B5, A5PLK6, D3Z6S9, E7FA21, G3UYX5, O75747, O75901, O88480, O88869, Q2T9P0, Q3UMB5, Q3UPC7, Q3URV1, Q402B2, Q4R9E9, Q5SUS0, Q5T0N1, Q5XI56, Q5XX13, Q642P2, Q6DHV5, Q6INI0, Q6P2C0, Q7L0X2, Q80X60, Q86VV8, Q86WZ0, Q8CDN1, Q8IV33, Q8IXR9, Q8K342, Q8N7B9, Q8N7X0, Q8ND61, Q8NE09, Q8NG48, Q8R4Y8, Q8TDY2, Q8TEV9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

168 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance148
Likely benign8
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

3743 predictions. Top by Δscore:

VariantEffectΔscore
1:182472461:G:GTdonor_gain1.0000
1:182472518:G:GTdonor_gain1.0000
1:182472519:A:Tdonor_gain1.0000
1:182472528:GGGTG:Gdonor_gain1.0000
1:182472529:GGTGG:Gdonor_gain1.0000
1:182472530:G:Tdonor_gain1.0000
1:182472558:G:GGdonor_gain1.0000
1:182530235:A:AGacceptor_gain1.0000
1:182530236:T:Gacceptor_gain1.0000
1:182530239:TCTA:Tacceptor_loss1.0000
1:182530240:CTA:Cacceptor_loss1.0000
1:182530241:TA:Tacceptor_loss1.0000
1:182530242:A:AGacceptor_gain1.0000
1:182530243:G:GTacceptor_gain1.0000
1:182530243:GA:Gacceptor_gain1.0000
1:182530243:GAA:Gacceptor_gain1.0000
1:182530243:GAAGA:Gacceptor_gain1.0000
1:182530358:AGTGG:Adonor_loss1.0000
1:182530359:GTG:Gdonor_gain1.0000
1:182530360:TGG:Tdonor_loss1.0000
1:182530362:G:Adonor_loss1.0000
1:182530362:G:GGdonor_gain1.0000
1:182530363:T:Gdonor_loss1.0000
1:182530364:GA:Gdonor_loss1.0000
1:182530365:AGTAT:Adonor_loss1.0000
1:182532657:CCCA:Cacceptor_loss1.0000
1:182532658:CCA:Cacceptor_loss1.0000
1:182532660:A:AGacceptor_gain1.0000
1:182532660:AGA:Aacceptor_loss1.0000
1:182532661:G:GAacceptor_loss1.0000

AlphaMissense

7239 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:182548817:T:AW976R0.995
1:182548817:T:CW976R0.995
1:182540346:G:CR865P0.994
1:182458361:T:AW47R0.992
1:182458361:T:CW47R0.992
1:182548705:T:AN938K0.992
1:182548705:T:GN938K0.992
1:182532762:T:CL822P0.989
1:182548401:A:CK918N0.989
1:182548401:A:TK918N0.989
1:182540393:G:CD881H0.988
1:182540345:C:AR865S0.987
1:182540394:A:CD881A0.987
1:182548400:A:TK918I0.987
1:182551101:T:CF979L0.987
1:182551103:T:AF979L0.987
1:182551103:T:GF979L0.987
1:182460031:T:AW67R0.986
1:182460031:T:CW67R0.986
1:182548423:T:CF926L0.986
1:182548425:C:AF926L0.986
1:182548425:C:GF926L0.986
1:182527668:T:CF674S0.984
1:182527631:T:CF662L0.983
1:182527633:C:AF662L0.983
1:182527633:C:GF662L0.983
1:182532710:T:GY805D0.983
1:182548819:G:CW976C0.983
1:182548819:G:TW976C0.983
1:182540394:A:GD881G0.982

dbSNP variants (sampled 300 via entrez): RS1000031543 (1:182457333 C>T), RS1000066014 (1:182516014 A>G), RS1000080951 (1:182470135 C>G), RS1000104361 (1:182495773 C>A), RS1000145100 (1:182516270 G>A), RS1000150027 (1:182463957 T>A,C), RS1000153332 (1:182493677 ATGTGAATGCCCC>A), RS1000165282 (1:182482493 A>C), RS1000262155 (1:182482130 A>G), RS1000310684 (1:182540880 T>C,G), RS1000346552 (1:182451687 T>C), RS1000381442 (1:182534599 C>T), RS1000408333 (1:182484223 T>C), RS1000429942 (1:182508682 T>G), RS1000456035 (1:182491214 AATT>A,AATTATT)

Disease associations

OMIM: gene MIM:611012 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST005183_7Common carotid intima-media thickness3.000000e-06
GCST007565_112Morning person7.000000e-30
GCST011359_19Venous thromboembolism1.000000e-08

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0008328chronotype measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

10 total (human), top 10 by PubMed support.

ChemicalActions (top 5)PubMed papers
fluorene-9-bisphenolincreases expression1
CGP 52608affects binding, increases reaction1
Resveratrolaffects cotreatment, decreases expression1
Arsenicaffects methylation1
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression1
Copperaffects cotreatment, decreases expression1
Silicon Dioxidedecreases expression1
Aflatoxin B1decreases methylation1
Permethrinincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): venous thromboembolism